Top compounds associated with response to LYSMD1


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K86535717 CTRPv2 pan-cancer AAC 0.25 0.0009
mRNA nakiterpiosin CTRPv2 pan-cancer AAC 0.11 0.0009
mRNA parbendazole CTRPv2 pan-cancer AAC 0.1 0.001
mRNA ISOX CTRPv2 pan-cancer AAC 0.11 0.001
mRNA AZD0530 CCLE pan-cancer AAC -0.16 0.001
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.001
mRNA ciclopirox CTRPv2 pan-cancer AAC 0.11 0.001
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.001
mRNA FGIN-1-27 CTRPv2 pan-cancer AAC 0.24 0.001
mRNA darinaparsin CTRPv2 pan-cancer AAC 0.17 0.001
Download CSV